Kailera Therapeutics, Inc. (KLRA)
16.54
-0.63
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Kailera Therapeutics Enterprise Value : 1.319B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.319B |
| August 20, 2026 | 1.357B |
| August 19, 2026 | 1.468B |
| August 18, 2026 | 1.405B |
| August 17, 2026 | 1.493B |
| August 14, 2026 | 1.419B |
| August 13, 2026 | 1.423B |
| August 12, 2026 | 1.503B |
| August 11, 2026 | 1.539B |
| August 10, 2026 | 1.554B |
| August 07, 2026 | 1.512B |
| August 06, 2026 | 1.539B |
| August 05, 2026 | 1.449B |
| August 04, 2026 | 1.441B |
| August 03, 2026 | 1.339B |
| July 31, 2026 | 1.289B |
| July 30, 2026 | 1.304B |
| July 29, 2026 | 1.281B |
| July 28, 2026 | 1.263B |
| July 27, 2026 | 1.359B |
| July 24, 2026 | 1.386B |
| July 23, 2026 | 1.349B |
| July 22, 2026 | 1.399B |
| July 21, 2026 | 1.480B |
| July 20, 2026 | 1.415B |
| Date | Value |
|---|---|
| July 17, 2026 | 1.498B |
| July 16, 2026 | 1.468B |
| July 15, 2026 | 1.595B |
| July 14, 2026 | 1.558B |
| July 13, 2026 | 1.682B |
| July 10, 2026 | 1.774B |
| July 09, 2026 | 1.817B |
| July 08, 2026 | 1.914B |
| July 07, 2026 | 1.976B |
| July 06, 2026 | 2.114B |
| July 02, 2026 | 1.944B |
| July 01, 2026 | 1.792B |
| June 30, 2026 | 1.949B |
| June 29, 2026 | 3.291B |
| June 26, 2026 | 3.183B |
| June 25, 2026 | 3.160B |
| June 24, 2026 | 3.252B |
| June 23, 2026 | 3.252B |
| June 22, 2026 | 3.448B |
| June 18, 2026 | 3.062B |
| June 17, 2026 | 2.962B |
| June 16, 2026 | 2.887B |
| June 15, 2026 | 3.032B |
| June 12, 2026 | 2.931B |
| June 11, 2026 | 3.015B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Moderna, Inc. | 54.06B |
| Revolution Medicines, Inc. | 42.13B |
| Sana Biotechnology, Inc. | 1.079B |
| Parabilis Medicines, Inc. | 3.789B |
| Arrowhead Pharmaceuticals, Inc. | 12.07B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -111.31M |
| Total Expenses (Quarterly) | 111.31M |
| EPS Diluted (Quarterly) | -0.8587 |
| Earnings Yield | -10.22% |